Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB). 2012

Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
Centro de Biologia Molecular Estrutural, CEBIME-UFSC, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis-SC, Brasil.

Tuberculosis (TB) is a major infectious disease caused by Mycobacterium tuberculosis (Mtb). According to the World Health Organization (WHO), about 1.8 million people die from TB and 10 million new cases are recorded each year. Recently, a new series of naphthylchalcones has been identified as inhibitors of Mtb protein tyrosine phosphatases (PTPs). In this work, 100 chalcones were designed, synthesized, and investigated for their inhibitory properties against MtbPtps. Structure-activity relationships (SAR) were developed, leading to the discovery of new potent inhibitors with IC(50) values in the low-micromolar range. Kinetic studies revealed competitive inhibition and high selectivity toward the Mtb enzymes. Molecular modeling investigations were carried out with the aim of revealing the most relevant structural requirements underlying the binding affinity and selectivity of this series of inhibitors as potential anti-TB drugs.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
September 2023, ACS omega,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
February 2010, Bioorganic & medicinal chemistry,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
December 2008, Bioorganic & medicinal chemistry letters,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
May 2007, Bioorganic & medicinal chemistry letters,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
November 2017, Molecular diversity,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
October 2023, Bioorganic & medicinal chemistry letters,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
September 2011, European journal of medicinal chemistry,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
April 2023, Bioorganic & medicinal chemistry,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
September 2010, Organic & biomolecular chemistry,
Louise Domeneghini Chiaradia, and Priscila Graziela Alves Martins, and Marlon Norberto Sechini Cordeiro, and Rafael Victorio Carvalho Guido, and Gabriela Ecco, and Adriano Defini Andricopulo, and Rosendo Augusto Yunes, and Javier Vernal, and Ricardo José Nunes, and Hernán Terenzi
January 2019, Frontiers in chemistry,
Copied contents to your clipboard!